Skip to content
request demo
text
Trusted by 100+ leading biopharma companies

AI-Powered Intelligence Platform Built for Medical Affairs

Ferma monitors conferences, maps evidence gaps, and drafts cited responses to medical inquiries, so your team owns the science, not the assembly.
request demo

Medical Affairs Is Drowning in Science, and Synthesis Hasn’t Kept Pace

Signal Is Outpacing the Team
 
A single major congress brings thousands of abstracts in days, on top of tens of thousands of publications a year and constant pipeline movement. The science arrives faster than anyone can read it.
Every Claim Must Be Sourced
 
Medical Affairs is non-promotional. Nothing reaches an HCP without a citation, so the team spends hours sourcing and compliance-checking before anything ships.
Evidence Gaps Surface Too Late
 

Where a drug’s evidence is thin — by endpoint, subgroup, or geography — often surfaces only when a payer or competitor raises it. Finding it first takes weeks of manual review.

Medical Affairs Agentic Workflows

Committee-Ready Deliverables for Every Stage of the Deal Cycle Finished, Fully-Cited Deliverables for Every Use Case.
scientific intelligence
Real-Time Scientific Intelligence
Live monitoring across congresses, publications, and native-language China sources.
Conference Coverage
Conference Intelligence
Track the readouts, sessions, and scientific leaders that matter to your assets, with every takeaway cited to source.
field inquiry
Field Inquiry Intelligence
Triages inbound medical inquiries, ranks by volume and risk, drafts cited responses, and flags off-label questions for MLR review.
Evidence Gap Analysis
Evidence Gap Analysis
Where a drug’s evidence is thin, by endpoint, sub-population, and comparator — ranked by priority, every gap linked to source.
KOL Mapping & Sentiment
KOL & Scientific-Leader Mapping
Experts mapped across publications, trials, and congress activity.
publication
Publication Planning Intelligence
Competitor publication velocity and abstract trends by therapeutic area.
scientific narrative
Scientific Narrative & Platform
Build and maintain the scientific lexicon and messaging, fully sourced.
Com Lands
Competitive Evidence Landscape
Competitor evidence, including ongoing trials, scored and ranked.
advisory board prep
Advisory Board Prep
Per-asset evidence briefs, always current, ready for review.
medical insights
Medical Insights Engine
Aggregate and structure field and congress insights into actionable themes.
literature surveillance
Literature Surveillance
Continuous, cited monitoring of the literature for your assets.
Custom
Custom Agentic Workflow
Tailored to your workflow — define the plan, data sources, and output.

Three Steps to a Finished Medical Affairs Deliverable

S T E P  1

Set Up Your Coverage

Configure your therapeutic areas, assets, and congresses. Your evidence framework — inclusion criteria, endpoints, comparators — encoded as the Agentic Workflow’s plan.

S T E P  2

Monitor & Synthesize

Agentic Workflows track congresses, publications, and inquiries continuously, applying your encoded methodology to structure and rank what matters.

S T E P  3

Receive Your Cited Deliverable

Session summary, gap map, or inquiry brief — fully sourced, exportable to PowerPoint, Excel, or PDF, ready for review.

Why Medical Affairs Teams Switch to Ferma

Ferma
General AI/Legacy Tools
End-to-end workflow

High
Conference intelligence, evidence landscape, gap analysis, and cited response drafting in one workflow
None
Review-ready deliverables

High
Finished, cited deliverable; methodology executed end to end
None
Comprehensive coverage

High
Trials, publications, congresses, regulatory, and China, all linked at the asset level
Medium
In-depth analysis

High
Endpoint and subgroup evidence, gap analysis, competitive evidence
Low
Near-real-time monitoring

High
Continuous tracking of congresses, publications, and competitor evidence
None
Ferma Fierce ad
quote

During ASCO, we used to lose the first two days just building the readout deck before we could even talk about what it meant. Now the deck is done by lunch, so my team spends the week on positioning instead of assembly.

Director
Medical Affairs, Top-15 Global Biopharma

Our evidence gap reviews used to happen once a quarter, so we often found the weak spot after a payer already had. Now the gap map updates continuously and every line traces to its source, so we catch the thin evidence early and walk into reviews already knowing where we stand.

Senior Director
Global Medical Affairs, Top-10 Pharma

After a big readout, our inbox used to bury the team in duplicate questions for a week straight. Ferma clusters and drafts the responses with sources attached, so my reviewers are editing, not writing from scratch.

Head of Medical Information
Mid-Size Biopharma
CTA Home

Medical Affairs teams at leading pharma companies trust Ferma.

Request Demo

Frequently Asked Questions

How is Ferma different from congress and literature monitoring tools for Medical Affairs?

Conference databases, literature tools, and pipeline trackers surface sessions, papers, and events, but leave the reading, ranking, and citing to your team. Ferma's Agentic Workflows go further: they deliver the sessions and readouts that matter to your assets, each summarized and cited to source. Not a list to work through yourself, a finished deliverable your team can act on and share.

How does Ferma support the compliance requirements specific to Medical Affairs?

Because Medical Affairs is non-promotional, every claim Ferma produces is traced to its source, with full provenance on every output, so anything your team shares can be checked back to the evidence. Content that looks off-label is flagged for your team to review, and citations aren't a finishing touch, they're built into every Agentic Workflow by design. Ferma supports your compliance process; your team and MLR keep final review and sign-off.

What is Ferma’s Fierce AI Innovation Award recognition?

Ferma was named a Finalist in the 2026 Fierce AI Innovation Awards, in the AI Innovation in Medical Affairs category, recognizing its Real-Time Scientific Intelligence, Evidence Gap Analyzer, and Field Inquiry Intelligence Agentic Workflows.